Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

13204

Sigma-Aldrich

β-tri-Calcium phosphate

puriss. p.a., ≥98% β-phase basis (unsintered powder)

Synonyme(s) :

β-TCP, β-Tricalcium phosphate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
Ca3O8P2
Numéro CAS:
7758-87-4
Poids moléculaire :
310.18
Numéro CE :
231-840-8
Numéro MDL:
MFCD00015984
Code UNSPSC :
12352302
ID de substance PubChem :
329750099
Nomenclature NACRES :
NA.55

Qualité

puriss. p.a.

Niveau de qualité

200

Pureté

≥98% β-phase basis (unsintered powder)

Forme

powder

Impuretés

≤250 mg/kg total sulfur (as SO4) (ICP)
≤50 mg/kg total heavy metals (as lead)

Traces d'anions

chloride (Cl-): ≤100 mg/L

Traces de cations

As: ≤0.5 mg/kg
Ba: ≤10 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤5 mg/kg
Cu: ≤1 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤1 mg/kg
Pb: ≤5 mg/kg
Zn: ≤10 mg/kg

InChI

1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6

Clé InChI

QORWJWZARLRLPR-UHFFFAOYSA-H

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

β-tri-Calcium phosphate belongs to the category of calcium-phosphate based ceramics, which has been involved in the preparation of a new biosynthetic material possessing morphogenetic activity that is used as a bone implant.

Remarque sur l'analyse

Phase Composition (by XRD analysis)
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity ß-Tricalcium phosphate after sintering at 1100C.
ß-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 4

1 of 4

Calcium phosphate tribasic suitable for plant cell culture, BioReagent, powder

Sigma-Aldrich

C3161

Calcium phosphate tribasic

Hydroxyapatite powder, 2.5 &#956;m

Sigma-Aldrich

900195

Hydroxyapatite

Hydroxyapatite synthetic, 99.8% trace metals basis (excludes Mg)

Sigma-Aldrich

574791

Hydroxyapatite

Hydroxyapatite powder, 5&#160;&#956;m

Sigma-Aldrich

900204

Hydroxyapatite

A new polyphosphate calcium material with morphogenetic activity
Muller.G.EW, et al.
Materials Letters, 148, 163-166 (2015)
Timo Brandenburger et al.
Shock (Augusta, Ga.), 42(3), 234-238 (2014-07-01)
Remote ischemic preconditioning (RIPC) is an easily applicable method for protecting the heart against a subsequent ischemia and reperfusion (I/R) injury. However, the exact molecular mechanisms underlying RIPC are unknown. We examined the involvement of microRNAs (miRNAs) and in particular
Krzysztof W Luczynski et al.
Journal of biomedical materials research. Part A, 101(1), 138-144 (2012-07-25)
This paper is concerned with reliable and physically sound elasticity determination of rapid-prototyped tissue engineering scaffolds made of poly-L-lactide (PLLA), with and without small portions of tricalcium phosphate (TCP) inclusions. At the level of overall scaffolds, that is, that of
A H Choi et al.
Journal of dental research, 92(10), 853-859 (2013-07-17)
The purpose of coatings on implants is to achieve some or all of the improvements in biocompatibility, bioactivity, and increased protection from the release of harmful or unnecessary metal ions. During the last decade, there has been substantially increased interest
Floor C J van de Watering et al.
Journal of controlled release : official journal of the Controlled Release Society, 164(3), 283-290 (2012-07-18)
Clinical application of calcium phosphate cement (CPC; with incorporated polymeric porogens) in an injectable form implicates that loading methods for growth factors are limited. In view of this, the current study evaluated the in vitro and in vivo release kinetics
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique